Stay updated with breaking news from Gene Therapy Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
11.08.2022 - TSHA-120 treated patients in GAN demonstrated durable improvement and recoverability of sensory nerve amplitude potential (SNAP), a definitive clinical endpoint, compared to natural history TSHA-120 commercial grade and clinical trial material ...
This past week in healthcare investigations
Passage Bio, Inc. (NASDAQ:NASDAQ:PASG) Q2 2022 Earnings Conference Call August 04, 2022, 08:30 AM ET Company Participants Stuart Henderson - VP of Corporate Development and IR Edgar Cale -...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
06.07.2022 - President, Founder and Chief Executive Officer to participate in “AAV Gene Therapy: Delivery and Beyond” panel discussion on Wednesday, July 13, 2022 at 10:00 am ETDALLAS, July 06, 2022 (GLOBE NEWSWIRE) - Taysha Gene Therapies, Inc. (Nasdaq: ...